2qd6: Difference between revisions

Revision as of 11:37, 28 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:2qd6.png

Template:STRUCTURE 2qd6

HIV-1 Protease Mutant I50V with potent Antiviral inhibitor GRL-98065HIV-1 Protease Mutant I50V with potent Antiviral inhibitor GRL-98065

Template:ABSTRACT PUBMED 17696515

About this StructureAbout this Structure

2QD6 is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.

ReferenceReference

Potent new antiviral compound shows similar inhibition and structural interactions with drug resistant mutants and wild type HIV-1 protease., Wang YF, Tie Y, Boross PI, Tozser J, Ghosh AK, Harrison RW, Weber IT, J Med Chem. 2007 Sep 6;50(18):4509-15. Epub 2007 Aug 16. PMID:17696515

Page seeded by OCA on Mon Jul 28 11:37:04 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:2qd6.jpg|left|200px]]
+{{Seed}}
+[[Image:2qd6.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2qd6|  PDB=2qd6  |  SCENE=  }}
-'''HIV-1 Protease Mutant I50V with potent Antiviral inhibitor GRL-98065'''
+===HIV-1 Protease Mutant I50V with potent Antiviral inhibitor GRL-98065===
-==Overview==
+<!--
-The potent new antiviral inhibitor GRL-98065 (1) of HIV-1 protease (PR) has been studied with PR variants containing the single mutations D30N, I50V, V82A, and I84V that provide resistance to the major clinical inhibitors. Compound 1 had inhibition constants of 17-fold, 8-fold, 3-fold, and 3-fold, respectively, for PR(D30N), PR(I50V), PR(V82A), and PR(I84V) relative to wild type PR. The chemically related darunavir had similar relative inhibition, except for PR(D30N), where inhibitor 1 was approximately 3-fold less potent. The high resolution (1.11-1.60 Angstrom) crystal structures of PR mutant complexes with inhibitor 1 showed small changes relative to the wild type enzyme. PR(D30N) and PR(V82A) showed compensating interactions with inhibitor 1 relative to those of PR, while reduced hydrophobic contacts were observed with PR(I50V) and PR(I84V). Importantly, inhibitor 1 complexes showed fewer changes relative to wild type enzyme than reported for darunavir complexes. Therefore, inhibitor 1 is a valuable addition to the antiviral inhibitors with high potency against resistant strains of HIV.
+The line below this paragraph, {{ABSTRACT_PUBMED_17696515}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 17696515 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_17696515}}
 ==About this Structure==
@@ Line 33: / Line 37: @@
 [[Category: Hydrolase]]
 [[Category: Protease inhibitor]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Apr 24 09:40:48 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 11:37:04 2008''